StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.66+0.06 (+3.75%)

Close on Nov 17, 2026Market cap $4.22MP/E –Yield –

Alaunos Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Alaunos Therapeutics's enterprise value was $3.88M on Nov 11, 2026, against $5.43M a year earlier. Over the last 5 years it ranged from $818.57K to $496.27M, with a median of $6.42M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.88M-25.2%
2025Dec 31, 2025$5.19M+279.3%
2024Dec 31, 2024$1.37M-72.1%
2023Dec 29, 2023$4.90M-95.6%
2022Dec 30, 2022$111.24M-33.8%
2021Dec 31, 2021$168.07M-58.4%
2020Dec 31, 2020$404.20M-47.2%
2019Dec 31, 2019$766.00M+227.2%
2018Dec 31, 2018$234.12M-53.5%
2017Dec 29, 2017$503.29M-17.5%
2016Dec 30, 2016$610.05M-34.0%
2015Dec 31, 2015$923.84M+94.7%
2014Dec 31, 2014$474.49M+39.7%
2013Dec 31, 2013$339.55M+43.9%
2012Dec 31, 2012$235.88M+28.9%
2011Dec 30, 2011$182.94M+14.5%
2010Dec 31, 2010$159.81M–

More Alaunos Therapeutics figures

See a number that looks wrong?